Anticoagulants Market: Global Industry Analysis and Forecast, 2014 - 2020

Submitted by: Submitted by

Views: 36

Words: 953

Pages: 4

Category: Business and Industry

Date Submitted: 02/24/2015 12:58 AM

Report This Essay

Anticoagulants Market: Global Industry Analysis and Forecast, 2014 - 2020

Persistence Market Research

Anticoagulants Market: Global Industry Analysis and Forecast, 2014 - 2020

Persistence Market Research

1

Anticoagulants Market: Global Industry Analysis and Forecast, 2014 - 2020 Persistence Market Research Released New Market Report on “Anticoagulants Market: Global Industry Analysis and Forecast, 2014 - 2020”.

Anticoagulants are used to eliminate the risk of blood clots in the body. Blood clots are formed when platelets stick together and proteins in the blood bind together to form a solid mass. Generally, blood clots play an important role in stopping external bleeding caused by any injury to the skin. However, when blood clots form in the blood vessels, they can be dangerous as they can block blood circulation. Blood clots in arteries or the heart can obstruct blood flow and cause a heart attack. Such clots in blood vessels in the brain can cause a stroke. Anticoagulants stop the platelets from adhering to one another and clotting proteins from binding together. These are commonly used in the treatment of deep vein thrombosis (DVT), pulmonary embolism, atrial fibrillation, and managing high and moderate risk of stroke.

Buy Full Report: http://www.persistencemarketresearch.com/market-research/anticoagulantsmarket.asp

Anticoagulants are mainly categorized as herapins, warfarin, low molecular weight heparins (LMWHs), factor Xa inhibitors, and direct thrombin inhibitors (DTIs). Heparin is an injectable anticoagulant widely used in hospitals for rapid anticoagulation. LMWHs are administered about twice a day as subcutaneous injections to treat DVT. These are more convenient to use than heparins, as LMWHs can be self injected at home. Warfarin is usually prescribed as part of long-term anticoagulant therapy for patients with atrial fibrillation to help reduce the risk of stroke by more than 60%. The global anticoagulants market is categorized based on various...